Make better investment decisions with Simply Wall St’s simple, visual tools that give you a competitive edge.
Eramet (ENXTPA:ERA) has drawn fresh attention after a sharp 2025 earnings decline, a planned €500 million capital increase, asset disposals, dividconclude suspension, and management modifys, all bundled into a three pillar recovery plan.
See our latest analysis for ERAMET.
The capital increase and dividconclude suspension have quickly fed into sentiment, with Eramet’s share price down 39.34% over the past 30 days but roughly flat on a 90 day share price basis. The 3 year total shareholder return decline of 43.52% points to longer running pressure and fading momentum.
If this kind of volatility has you seeing wider than a single miner, it could be a good moment to scan our screener of 30 best rare earth metal stocks for potential alternatives in the broader materials space.
After a year marked by a 54% adjusted EBITDA drop, net losses, a suspconcludeed dividconclude and a planned €500 million capital increase, is Eramet’s current share price already reflecting all that pain, or could this turmoil be setting up a purchaseing opportunity that markets are not fully pricing in?
On the latest numbers, ERAMET trades on a P/S of 0.5x, which sees low relative to peers and sector averages for a €48.98 share price.
P/S compares the company’s market value to its revenue, so it is often applyd when earnings are weak or loss creating, as is the case here with a €97m net loss. For a miner with sizeable operations across manganese, nickel, and mineral sands, this kind of revenue based lens assists you focus on what investors are currently paying for each euro of sales, rather than profits that can swing with the cycle.
Right now ERAMET screens as “good value” on this measure versus three separate benchmarks. The current 0.5x P/S sits well below the peer average of 3.5x, well below the European metals and mining average of 1.1x, and below an estimated fair P/S of 3.4x that our model suggests the market could relocate towards if sentiment and fundamentals lined up more closely.
Explore the SWS fair ratio for ERAMET
Result: Price-to-Sales of 0.5x (UNDERVALUED)
However, you still required to weigh execution risks around the €500 million capital increase, as well as the impact of recent net losses and dividconclude suspension on long term investor confidence.
Find out about the key risks to this ERAMET narrative.
While ERAMET’s 0.5x P/S ratio suggests good value, our DCF model notifys a very different story. In that view, the current share price of €48.98 sits well above an estimated future cash flow value of €2.15, which raises a clear question about how much cash the business can realistically generate over time.
Leave a Reply